Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02570828 · ClinicalTrials.gov registry record · Phase 1

Thermal Imaging in Neonates: A Feasibility Study in Healthy Babies and Babies With Suspected TTN

A Phase 1 study, sponsored by Massachusetts General Hospital.

Completed
Registry status
Phase 1
Development phase
25
Enrollment target

NCT02570828: Completed Phase 1 study, sponsored by Massachusetts General Hospital.

NCT02570828 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02570828, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Phase 1
Development phase
25 participants
Enrollment target

Study Summary

This is a study to evaluate thermal imaging as a technology to monitor the normal clearing of amniotic fluid from healthy newborns and newborns suspected of having a condition called transient tachypnea of the newborn, or TTN. Thermal images are taken using an imaging device that attaches to an iPhone. This device, commercially known as FLIR ONE, creates a non-identifiable image based on the heat pattern of an object. In this case, the object is a child's chest and back. It does not emit any radiation like an x-ray does.

Interventions

  • DEVICE Thermal Imaging

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2015-10
Est. Completion 2016-07
Phase Phase 1

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02570828

The ClinicalTrials.gov registry entry for NCT02570828 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Thermal Imaging is the first listed.

NCT02570828 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02570828 about?

NCT02570828 is a clinical study titled "Thermal Imaging in Neonates: A Feasibility Study in Healthy Babies and Babies With Suspected TTN". This is a study to evaluate thermal imaging as a technology to monitor the normal clearing of amniotic fluid from healthy newborns and newborns suspected of having a condition called transient tachypnea of the newborn, or TTN. Thermal images are taken using an imaging device that attaches to an iPho...

What is the current status of trial NCT02570828?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2015-10. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02570828?

The interventions under investigation include: Thermal Imaging (DEVICE).

Who is sponsoring clinical trial NCT02570828?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.